ECTRIMS 2019: Early treatment of MS leads to decrease in total costs

Korinna Karampampa | ECTRIMS 2019 | Septttember 13, 2019

Föreläsare: Korinna Karampampa

A larger decrease in total costs was observed in patients with MS who received their first disease modifying therapies early, which could potentially be explained by a slower disease progression leading to maintained work capacity.